Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fecal bacteria and short‐chain fatty acids in irritable bowel syndrome: Relations to subtype

30 Jun 2024

Abstract excerpt

BACKGROUND: The relationship between gut microbiota and irritable bowel syndrome (IBS) subtype is unclear. We aimed to explore whether differences in fecal bacteria composition and short-chain fatty acid (SCFA) levels were associated with subtypes and symptoms of IBS. METHODS: All participants delivered fecal samples and self-reports on IBS Symptom Severity Score (IBS-SSS), Bristol Stool Scale (BSS), and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clostridium difficile and Clostridium perfringens research
Share to Gastrointestinal motility and disorders
Share to Gut microbiota and health

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38946176
DOI: 10.1111/nmo.14854

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fecal bacteria and short‐chain fatty acids in irritable bowel syndrome: Relations to subtypePMID 38946176Read ↗

Mucosa-Associated Microbiota in Patients with Irritable Bowel Syndrome: A Comparison of SubtypesSemantic proximity Read ↗

Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea‐predominant irritable bowel syndromeSemantic proximity Read ↗

Microbiota-Short Chain Fatty Acid Relationships Underlie Clinical Heterogeneity and Identify Key Microbial Targets in Irritable Bowel Syndrome (IBS)Semantic proximity Read ↗

Fecal Microbiota Profiling in Patients with Irritable Bowel Syndrome and Small Intestinal Bacterial OvergrowthSemantic proximity Read ↗

Alterations in gut microbiome composition and function in irritable bowel syndrome and increased probiotic abundance with daily supplementationSemantic proximity Read ↗

Fecal Microbiota Characteristics in Constipation-Predominant and Mixed-Type Irritable Bowel SyndromeSemantic proximity Read ↗

Two microbiota subtypes identified in Irritable Bowel Syndrome with distinct responses to the low-FODMAP dietSemantic proximity Read ↗

Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome.Semantic proximity Read ↗

No difference in small bowel microbiota between patients with irritable bowel syndrome and healthy controlsSemantic proximity Read ↗

Compositional and Functional Changes in the Gut Microbiota in Irritable Bowel Syndrome PatientsSemantic proximity Read ↗

Unraveling the ties between irritable bowel syndrome and intestinal microbiotaSemantic proximity Read ↗

Structural alterations of faecal and mucosa‐associated bacterial communities in irritable bowel syndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.